ACA
Avoro Capital Advisors Portfolio holdings
AUM
$5.71B
This Quarter Return
+0.51%
1 Year Return
+11.37%
3 Year Return
+255.37%
5 Year Return
+558.9%
10 Year Return
+18,722.72%
AUM
$6.74B
AUM Growth
+$6.74B
(+0.72%)
Cap. Flow
+$283M
Cap. Flow
% of AUM
4.2%
Top 10 Holdings %
Top 10 Hldgs %
73.21%
Holding
39
New
2
Increased
16
Reduced
2
Closed
–
Top Buys
| 1 |
Sarepta Therapeutics
SRPT
|
$65.5M |
| 2 |
DICE
DICE Therapeutics, Inc. Common Stock
DICE
|
$40.8M |
| 3 |
BioMarin Pharmaceuticals
BMRN
|
$37.9M |
| 4 |
Apellis Pharmaceuticals
APLS
|
$32.1M |
| 5 |
Krystal Biotech
KRYS
|
$27.2M |
Top Sells
| 1 |
SGEN
Seagen Inc. Common Stock
SGEN
|
$16.8M |
| 2 |
Amylyx Pharmaceuticals
AMLX
|
$4.6M |
Sector Composition
| 1 | Healthcare | 99.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
HZNP
1
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $764M | 11.33% | 7,000,000 | – | – |
|
|
2
Apellis Pharmaceuticals
APLS
$3.48B
| $733M | 10.87% | 11,111,111 +486,111 | +5% | +$32.1M |
|
3
United Therapeutics
UTHR
$13.8B
| $643M | 9.53% | 2,870,000 +5,000 | +0.2% | +$1.12M |
|
|
4
Sarepta Therapeutics
SRPT
$1.78B
| $503M | 7.46% | 3,650,000 +475,000 | +15% | +$65.5M |
|
5
argenx
ARGX
$43.6B
| $480M | 7.11% | 1,287,500 +21,945 | +2% | +$8.18M |
|
6
Madrigal Pharmaceuticals
MDGL
$9.76B
| $404M | 5.99% | 1,666,666 +6,666 | +0.4% | +$1.61M |
|
|
7
BioMarin Pharmaceuticals
BMRN
$11.2B
| $384M | 5.69% | 3,945,000 +389,445 | +11% | +$37.9M |
|
|
SGEN
8
DELISTED
Seagen Inc. Common Stock
SGEN
| $365M | 5.41% | 1,801,906 -83,094 | -4% | -$16.8M |
|
9
Ascendis Pharma
ASND
$11.8B
| $357M | 5.29% | 3,325,000 +225,000 | +7% | +$24.1M |
|
10
Amicus Therapeutics
FOLD
$2.34B
| $303M | 4.49% | 27,300,000 +500,000 | +2% | +$5.55M |
|
11
Alnylam Pharmaceuticals
ALNY
$58.5B
| $221M | 3.28% | 1,105,000 | – | – |
|
|
MRTX
12
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $207M | 3.06% | 5,555,555 | – | – |
|
13
Xenon Pharmaceuticals
XENE
$2.98B
| $175M | 2.6% | 4,900,000 | – | – |
|
|
ISEE
14
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $165M | 2.45% | 6,800,000 +50,000 | +0.7% | +$1.22M |
|
|
15
Krystal Biotech
KRYS
$4.27B
| $140M | 2.08% | 1,750,000 +340,000 | +24% | +$27.2M |
|
16
Kymera Therapeutics
KYMR
$2.95B
| $114M | 1.69% | 3,855,000 +5,000 | +0.1% | +$148K |
|
|
DICE
17
DELISTED
DICE Therapeutics, Inc. Common Stock
DICE
| $113M | 1.68% | 3,950,000 +1,424,445 | +56% | +$40.8M |
|
|
CBAY
18
DELISTED
Cymabay Therapeutics
CBAY
| $89.8M | 1.33% | 10,300,000 | – | – |
|
19
BioCryst Pharmaceuticals
BCRX
$1.74B
| $86.9M | 1.29% | 10,420,000 +1,370,000 | +15% | +$11.4M |
|
20
Syndax Pharmaceuticals
SNDX
$1.41B
| $56M | 0.83% | 2,650,000 | – | – |
|
21
Nuvalent
NUVL
$5.52B
| $49.3M | 0.73% | 1,888,888 +333,333 | +21% | +$8.7M |
|
22
Iovance Biotherapeutics
IOVA
$807M
| $42.9M | 0.64% | 7,020,000 | – | – |
|
23
Avidity Biosciences
RNA
$5.99B
| $38.5M | 0.57% | 2,510,000 +460,000 | +22% | +$7.06M |
|
24
Kura Oncology
KURA
$686M
| $38M | 0.56% | 3,105,000 | – | – |
|
25
MannKind Corp
MNKD
$1.41B
| $37.3M | 0.55% | 9,100,000 | – | – |
|